AXL and non-small cell lung carcinoma: 2022, Kim et al. 2023, Le et al. 2021). Moreover, CD73/NT5E has also been reported in NSCLC cells to be involved in signalling cascades which control proteins involved in EGFR‐TKI resistance including AXL (Zhu et al. 2024) and MET (Yoshida et al. 2022).